scispace - formally typeset
Open AccessJournal ArticleDOI

The role of interleukin-6 signaling in nervous tissue.

Reads0
Chats0
TLDR
A modified, recombinant dimerized version of sgp130 (sgp130Fc) has successfully been used to block inflammatory processes in mice and may also be used in the clarification of IL-6 trans-signaling in neurological diseases.
About
This article is published in Biochimica et Biophysica Acta.The article was published on 2016-06-01 and is currently open access. It has received 313 citations till now. The article focuses on the topics: Neurotrophic factors & Neurodegeneration.

read more

Citations
More filters
Journal ArticleDOI

Inflammation as a central mechanism in Alzheimer's disease

TL;DR: An overview of inflammation in AD is provided and a detailed coverage of a number of microglia‐related signaling mechanisms that have been implicated in AD are reviewed.
Journal ArticleDOI

Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update.

TL;DR: An overview of basic concept of IL- 6 signaling pathway as well as the interplay between IL-6 and renal-resident cells, including podocytes, mesangial cells, endothelial cells, and tubular epithelial cells are provided.
Journal ArticleDOI

Post-stroke inflammation-target or tool for therapy?

TL;DR: The cell biology of the post-stroke inflammatory response is summarized and pharmacological interventions targeting inflammation in the acute phase after a stroke that may be used alone or in combination with recanalization therapies are discussed.
Journal ArticleDOI

Repopulating Microglia Promote Brain Repair in an IL-6-Dependent Manner

TL;DR: It is concluded that microglia in the mammalian brain can be manipulated to adopt a neuroprotective and pro-regenerative phenotype that can aid repair and alleviate the cognitive deficits arising from brain injury.
Journal ArticleDOI

What does plasma CRP tell us about peripheral and central inflammation in depression

TL;DR: CRP appears to be a peripheral biomarker that reflects peripheral and central inflammation and seems well-suited for guiding immunotherapies targeting TNF and IL-6 in patients with MDD.
References
More filters
Journal ArticleDOI

Rating neurologic impairment in multiple sclerosis An expanded disability status scale (EDSS)

John F. Kurtzke
- 01 Nov 1983 - 
TL;DR: A new Expanded Disability Status Scale (EDSS) is presented, with each of the former steps (1,2,3 … 9) now divided into two (1.0, 1.5, 2.0 … 9).
Journal ArticleDOI

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

TL;DR: It is shown that IL-6, an acute phase protein induced during inflammation, completely inhibits the generation of Foxp3+ Treg cells induced by TGF-β, and the data demonstrate a dichotomy in thegeneration of pathogenic (TH17) T cells that induce autoimmunity and regulatory (Foxp3+) T Cells that inhibit autoimmune tissue injury.
Journal ArticleDOI

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

TL;DR: It is suggested that tau in Alzheimer brain is an abnormally phosphorylated protein component of PHF, the two major locations of paired-helical filaments in Alzheimer disease brain.
Journal ArticleDOI

Principles of interleukin (IL)-6-type cytokine signalling and its regulation.

TL;DR: This review focuses on recent progress in the understanding of the molecular mechanisms of IL-6-type cytokine signal transduction, with emphasis on the termination and modulation of the JAK/STAT signalling pathway mediated by tyrosine phosphatases, the SOCS (suppressor of cytokine signalling) feedback inhibitors and PIAS (protein inhibitor of activated STAT) proteins.
Journal ArticleDOI

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

TL;DR: The molecular cloning, structural analysis and functional expression of the cDNA encoding human B SF-2 indicated that BSF-2 is functionally and structurally unlike other known proteins.
Related Papers (5)